Last week marked the official launch of a campaign by the International Academy of Clinical Research (IAoCR) to change the way that training and education is carried out within the UK’s clinical research industry. The organization is calling for the introduction of accredited clinical research training with a recognised industry standard and demonstrable, measurable levels of competence.
A meeting was held to discuss how the industry can improve the way that training is carried out. It was attended by key stakeholders from pharmaceutical companies and CROs (Contract Research Organisations) with presentations from Dr Vincent Yeung from the MHRA (Medicines and Healthcare products Regulatory Agency), Dr Mike Hardman from IMI/EMTRAIN and Virendra Sharma MP, from the Health Select Committee.
CEO at IAoCR, Jacqueline Johnson North says: “Our event last week stimulated a great deal of debate about the increasing need for accredited training within the clinical research industry. Although there were many different opinions, it was unanimously agreed that there needs to be some form of regulated, recognised and accredited training.”
Accredited training has the potential to improve patient safety and public confidence in clinical research; reduce risks and mistakes; get drugs to market quicker; reduce repetitive training; and support the career progress of clinical research professionals, site staff and investigators.
Johnson North explains: “Currently, clinical research professionals and site staff receive full training before commencing any clinical research trial. This training covers standard operating procedures, general clinical research training and trial specific training; however there is rarely any meaningful measure of learning transfer and staff competence. We believe that by introducing a requirement for accredited, quality controlled training, trial operators will be able to reduce the level of repetitive general training and focus much more heavily on the trial specific training. The results will be four-fold – training time will be reduced, specific training will be improved, staff will feel more valued as their level of expertise is recognised and finally, skills and qualifications will become more transparent and more portable which will boost the industry by attracting and keeping quality staff.”
Attendees at the event agreed that there is a genuine need to create a better infrastructure for clinical research within the UK which needs to be introduced across all areas from universities through to the NHS as well as the commercial sector.
The IAoCR is now looking at ways to take this motion to Government and inspire debate. The IAoCR has requested information from all interested parties with a view to developing a working document outlining the need for a national clinical research training framework. For more information on the IAoCR, please visit www.iaocr.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.